Correction to: Systemic lupus erythematosus and C1q: A quantitative ELISA for determining C1q levels in serum (Biotechnology Journal (2009) 4, 8, DOI: 10.1002/biot.200800273);Systemic lupus erythematosus and C1q: A quantitative ELISA for determining C1q levels in serum

Biotechnology Journal

Volumn 4, Issue 8, 2009, Pages 1210-1214

  Dillon, Skyler P ^a   D'Souza, Anil ^a,b,c   Kurien, Biji T ^a,c   Scofield, R Hal ^a,b,c  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

C1q; ELISA; Serum; Systemic lupus erythematosus

Indexed keywords

BIOTECHNOLOGY; MEDICINE;

AVERAGE CONCENTRATION; COST EFFICIENCY; ELISA; HIGH-THROUGHPUT MEASUREMENTS; REPRODUCIBILITIES; SANDWICH ELISA; SERUM; SYSTEMIC LUPUS ERYTHEMATOSUS;

BODY FLUIDS;

COMPLEMENT COMPONENT C1Q;

ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH THROUGHPUT SCREENING; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 70350100445     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201090015     Document Type: Erratum

References (17)

1. Botto, M., Walport, M. J., C1q, autoimmunity and apoptosis. Immunobiology 2002, 205, 395-406.
2. Sontheimer, R.D., Racila, E., Racila, D. M., C1q: Its functions within the innate and adaptive immune responses and its role in lupus autoimmunity. J. Invest. Dermatol. 2005, 125, 14-23.
3. Bowness, P., Davies, K. A., Norsworthy, P. J., Athanassiou, P. et al., Hereditary C1q deficiency and systemic lupus erythematosus. QJM. 1994, 87, 455-464.
4. Kallel-Sellami, M., Baili-Klila, L., Zerzeri, Y., Laadhar, L. et al., Pediatric systemic lupus erythematosus with C1q deficiency. Ann. N.Y. Acad. Sci. 2007, 1108, 193-196.
5. Pickering, M. C., Botto, M., Taylor, P. R., Lachmann, P. J., Walport, M. J., Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv. Immunol. 2000, 76, 227-324.
6. Horak, P., Hermanova, Z., Zadrazil, J., Ciferska, H. et al., C1q complement component and -antibodies reflect SLE activity and kidney involvement. Clin. Rheumatol. 2006, 25, 532-536.
7. Horvath, L., Czirjak, L., Fekete, B., Jakab, L. et al., High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients. Clin. Exp. Rheumatol. 2001, 19, 667-672.
8. Van Hoeyveld, E., Bossuyt, X., Evaluation of seven commercial ELISA kits compared with the C1q solid-phase binding RIA for detection of circulating immune complexes. Clin. Chem. 2000, 46, 283-285.
9. Schuller, E., Helary, M., Determination in the nanogram range of C1q in serum and unconcentrated CSF by electroimmunodiffusion. J. Immunol. Methods 1983, 56, 159-165.
10. Delamarche, C., Berger, F., Pouplard, A., Emile, J., An ELISA technique for the measurement of C1q in cerebrospinal fluid. J. Immunol. Methods 1988, 114, 101-106.
11. Leyva-Cobian, F., Moneo, I., Mampaso, F., Sanchez-Bayle, M. et al., Familial C1q deficiency associated with renal and cutaneous disease. Clin. Exp. Immunol. 1981, 44, 173-180.
12. Hoekzema, R., Hannema, A. J., Swaak, T. J., Paardekooper, J., Hack, C. E., Low molecular weight C1q in systemic lupus erythematosus. J. Immunol. 1985, 135, 265-271.
13. Kishore, U., Sontheimer, R.D., Sastry, K.N., Zappi, E.G. et al., The systemic lupus erythematosus (SLE) disease autoantigen-calreticulin can inhibit C1q association with immune complexes. Clin. Exp. Immunol. 1997, 108, 181-190.
14. Gomo, Z. A., Henderson, L. O., High-density lipoprotein apolipoproteins in urine: II. Enzyme-linked immunoassay of apolipoprotein A-I. Clin. Chem. 1988, 34, 1781-1786.
15. Kunishima, S., Hayashi, K., Kobayashi, S., Naoe, T., Ohno, R., New enzyme-linked immunosorbent assay for glycocalicin in plasma. Clin. Chem. 1991, 37, 169-172.
16. Monaghan, D. A., Power, M. J., Fottrell, P. F., Sandwich enzyme immunoassay of osteocalcin in serum with use of an antibody against human osteocalcin. Clin. Chem. 1993, 39, 942-947.
17. Harris, L. J., Larson, S. B., Hasel, K.W., McPherson, A., Refined structure of an intact IgG2a monoclonal antibody. Biochemistry 1997, 36, 1581-1597.